首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.
【24h】

Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.

机译:类固醇抗性综合征儿童的初始类固醇敏感性预测移植后复发。

获取原文
获取原文并翻译 | 示例
           

摘要

Of children with idiopathic nephrotic syndrome, 10%-20% fail to respond to steroids or develop secondary steroid resistance (termed initial steroid sensitivity) and the majority progress to transplantation. Although 30%-50% of these patients suffer disease recurrence after transplantation, with poor long-term outcome, no reliable indicator of recurrence has yet been identified. Notably, the incidence of recurrence after transplantation appears reduced in patients with steroid-resistant nephrotic syndrome (SRNS) due to monogenic disorders. We reviewed 150 transplanted patients with SRNS to identify biomarkers that consistently predict outcome of SRNS after transplantation. In all, 25 children had genetic or familial SRNS and did not experience post-transplant recurrence. We reviewed phenotypic factors, including initial steroid sensitivity, donor type, age, ethnicity, time to ESRD, and time on dialysis, in the remaining 125 children. Of these patients, 57 (45.6%) developed post-transplant recurrence; 26 of 28 (92.9%) patients with initial steroid sensitivity recurred after transplantation, whereas only 26 of 86 (30.2%) patients resistant from the outset recurred (odds ratio, 30; 95% confidence interval, 6.62 to 135.86; P<0.001). We were unable to determine recurrence in two patients (one with initial steroid sensitivity), and nine patients did not receive initial steroids. Our data show that initial steroid sensitivity is highly predictive of post-transplant disease recurrence in this pediatric patient population. Because a pathogenic circulating permeability factor in nephrotic syndrome remains to be confirmed, we propose initial steroid sensitivity as a surrogate marker for post-transplant recurrence.
机译:具有特发性肾病综合征的儿童,10%-20%不能响应类固醇或产生次级类固醇抗性(称为初始类固醇敏感性)和大多数进展以移植。虽然30%-50%的这些患者在移植后患有疾病复发,但长期结果差,尚未确定复发的可靠指标。值得注意的是,由于单一的病症,移植后移植后复发发生率显得降低,因此由于单一的疾病,抗类固醇肾病综合征(SRNS)。我们审查了150名移植患者的SRNS,以鉴定移植后始终如一地预测SRN的结果的生物标志物。总共25名儿童遗传或家族性SRN,并且没有经历移植后复发。我们审查了表型因素,包括最初的类固醇敏感性,供体类型,年龄,种族,时间到剩余的125名儿童中的透析和时间。在这些患者中,57(45.6%)发育后移植后复发; 26个(92.9%)患者患者初始类固醇敏感性,移植后重复,而只有26个(30.2%)的患者,患者的重复重复(差距,30; 95%置信区间,6.62至135.86; p <0.001) 。我们无法确定两名患者(一种初始类固醇敏感性)的复发,九个患者没有收到初始类固醇。我们的数据显示,最初的类固醇敏感性是在这种儿科患者群体中移植后疾病复发的高度预测性。由于肾病综合征的致病性循环渗透因子仍有待确认,我们将初始类固醇敏感性提出作为移植后复发的替代标记物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号